55I LLC’s iShares Biotechnology ETF IBB Stock Holding History

55I LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$217K	Sell	1,856 -318	-15%	-$39.5K	0.01%	567
2022 Q2	$256K	Buy	+2,174	New	+$258K	0.01%	476
2022 Q1	–	Sell	-1,445	Closed	-$221K	–	528
2021 Q4	$221K	Sell	1,445 -354	-20%	-$54.8K	0.01%	470
2021 Q3	$291K	Buy	1,799 +180	+11%	+$30.3K	0.01%	406
2021 Q2	$265K	Buy	1,619 +71	+5%	+$10.9K	0.01%	338
2021 Q1	$233K	Buy	+1,548	New	+$246K	0.01%	280

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

55I LLC's IBB Position: Q3 2022 in Review

55I LLC reduced its iShares Biotechnology ETF (IBB) stake by 15% in Q3 2022, selling an estimated $39.5K and leaving 1,856 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #567.

55I LLC first reported a position in IBB in Q1 2021 and has held it in 6 quarters since. The position peaked at $291K in Q3 2021. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

55I LLC held 1,856 shares of iShares Biotechnology ETF worth $217K as of Q3 2022.
55I LLC sold 318 iShares Biotechnology ETF shares in Q3 2022, an estimated $39.5K.
iShares Biotechnology ETF made up 0.01% of 55I LLC's portfolio in Q3 2022, its #567 holding.
55I LLC first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 6 quarters since.
55I LLC's iShares Biotechnology ETF position peaked at $291K in Q3 2021.
829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.